Short Term Outcomes After PRoton and PhotoN RadiOtherapy for IDH Mutated Grade 2 and 3 Gliomas

RecruitingOBSERVATIONAL
Enrollment

320

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

February 1, 2025

Study Completion Date

November 1, 2025

Conditions
GliomaRadiotherapy; Complications
Interventions
RADIATION

proton therapy

Radiotherapy delivered with protons

RADIATION

photon therapy

Radiotherapy delivered with photons

Trial Locations (1)

Unknown

RECRUITING

Erasmus MC, Rotterdam

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medical Center Haaglanden

OTHER

collaborator

Leiden University Medical Center

OTHER

collaborator

HollandPTC

INDUSTRY

collaborator

Institute Verbeeten

OTHER

collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

collaborator

University Medical Center Groningen

OTHER

collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

collaborator

Maastro Clinic, The Netherlands

OTHER

lead

Erasmus Medical Center

OTHER

NCT06180434 - Short Term Outcomes After PRoton and PhotoN RadiOtherapy for IDH Mutated Grade 2 and 3 Gliomas | Biotech Hunter | Biotech Hunter